ABSTRACT. We examined long-term effects of neonatal hyperthyroidism on salivary secretions of nerve growth factor and epidermal growth factor in male and female mice at the age of 31 days. Hyperthyroidism was induced by thyroxine (T4) injections (0.4 wg/g body weightlday) during days 0-6. Littermate control mice were treated with vehicle. T4 treatment did not alter the amounts of protein secreted into saliva but hormone administration induced alteration in the types of protein secreted. T4 treatment decreased the contents of both nerve growth factor and epidermal growth factor secreted into the saliva. A Sephadex G-200 column chromatographic profile revealed the presence of two distinct nerve growth factor immunoreactive peaks, while epidermal growth factor immunoreactivity predominantly eluted as a single low molecular weight form. T4 treatment did not alter the molecular nature of their secretion, but the treatment decreased their contents. These results indicate an impairment in salivary secretion of nerve growth factor and epidermal growth factor long after T4 treatment has been discontinued. (Pediatr Res 20: 587-592,1986) Abbreviations NGF, nerve growth factor EGF, epidermal growth factor SMG, submandibular gland T4, thyroxine T3, triiodothyronine RIA, radioimmunoassay SDS, sodium dodecyl sulfate PAGE, polyacrylamide gel electrophoresis present study we have investigated the effects of neonatal hyperthyroidism on the secretions of SMG-NGF and EGF in epinephrine-provoked saliva. The results of these studies are reported herein.
Pups born within 16 h were pooled and randomly distributed, eight pups per dam. Each litter was divided into two groups. Four pups in each litter were given subcutaneous thyroxine (0.4 pg/g body weightlday) injections in a 5 p1 volume of alkaline saline. The remaining animals were given a similar volume of alkaline saline. Injections were made from birth (day 0) through day 6. Animals were inspected daily for maternal care and were changed to new cages. On day 2 1, the young ones were isolated from mother and maintained four per cage. Male and female animals were housed in separate cages.
On day 3 1 mice were anaesthetized with intraperitoneal injection of sodium pentobarbitol(60 mg/kg body weight). Salivation was induced by the intraperitoneal injection of epinephrine (3-6 mg/kg). We chose epinephrine, the most potent autonomic stimulant, since adrenergic innervation plays a major role in the protein secretory mechanism in SMG (8) . Animals showed individual variations in their ability to secrete saliva in response to epinephrine injection. Routinely, mice were given a single injection of epinephrine (3 mg/kg). If saliva secretion did not occur within 10 min a second injection of epinephrine was given. In control animals, saliva secretion occurred most often immediately after the first iniection, T4-treated mice often required a secdnd injection. In ail animals, saliva collected during the first 30 min was used. Saliva collection was made from the oral cavity through a microcapillary tube placed between the tongue and Mouse SMG contains NGF, EGF, and several other biolog-the floor of the mouth and transferred to polypropylene microically active substances in extraordinarily high concentrations. fuge tubes. Saliva collected from four animals was pooled and Both NGF and EGF are synthesized and stored in the secretory treated as a single sample. For each treatment group, six samples granules of the convoluted granular tubules of the SMG. The were collected. Saliva samples were stored at -70" C until further contents of the granules, including both NGF and EGF, are analysis. Total protein content was determined by the method secreted into saliva in response to various neurotransmitter stim-of Lowry et al. (9) , using bovine serum albumin as standard. Influence of T4 treatment on somatic growth and serum iodoare under multihormonal control (2) (3) (4) . However, it is not yet thyronines. Groups of litter-mate mice treated neonatally with clear whether hormones regulate the release mechanisms me-vehicle and T4 were sacrificed on day 3 1 by COz narcosis. Their diated by various neurotransmitter stimuli. Recent studies have body weight and nose-to-rump length were registered. In addirevealed a critical role for thyroid hormones in the regulation of tion, submandibular glands were removed and weighed. Blood the glandular contents of NGF and EGF (5-7). Therefore, in the was drawn from the inferior vena cava and used later for serum T4 and T3 determinations by specific RIAs (10, 1 I). Iz5I-labeled 588 LAKSHMANAN AND LANDEL Fig. 1 . Effect of T4 treatment on saliva protein secretion. Newborn pups were treated with vehicle or T4 (0.4 ~g / g body weightlday) during days 0-6. Animals were anaesthetized on day 3 1 and saliva was collected following epinephrine injection. A, saliva protein concentrations as determined by the method of Lowry et al. (9) . The values represent mean ( G E M ) of six samples in each sex. B, analysis of saliva proteins by SDS-gel electrophoresis. For convenience, the protein bands are numbered 1-9 in the order of decreasing molecular weights. Protein band 1 (50,000 daltons) appeared in both female and male mice. The content was much higher in females than in males. Neonatal T4 treatment increased its concentration slightly in females and markedly in males. Protein band 2 (43,000 daltons) was found only in animals which had been neonatally treated with T4. Conversely, protein band 3 (42,000 daltons) was present only in control female and male mice. Protein band 4 (40,000 daltons) appeared only in saliva of T4-treated female mice. Protein band 5 (37,000 daltons) was found in both female and male control mice. It decreased in T4-treated male mice and was absent in female mice. Protein band 6 (28,000 daltons) was seen only in control male mice. Protein band 7 (27,000 daltons) was present in control and T4-treated female littermates. This band was absent in control male mice but was present in T4-treated male mice. Protein band 8 (20,000 daltons) was found in higher concentration in control males compared to females. This band was absent in T4-treated female mice, but was present in smaller concentrations in hormone-treated male mice. Protein band 9 (1 5,000 daltons) was present in control female mice, and was absent in control male animals. This band was present in T4-treated female and male mice. GROWTH FACTORS IN MOUSE SALIVA 589 6%, Tris-HC1 0.2 M (pH 6.8), mercapthoethanol 1%. The samples were placed in a boiling water bath for 5 min before analysis by SDS-polyacrylamide slab gel electrophoresis (2 mm thickness) using the system of Laemmli (12) . A clear separation of salivary protein was achieved using a 10% running gel (1 1.5 cm in length) and a 4% stacking gel (3 cm in length). Following electrophoresis at 5 mA for 20 h, the gel was stained with Coomassie blue and destained. Standard proteins were corun and gels were scanned at 600 nm in an automatic computing densitometer (Model ACD-18, Gelman Scientific, Inc., Ann Arbor, MI).
NGF and EGF RIA. NGF concentration in saliva was quantified by liquid phase double antibody RIA using P-NGF antiserum containing two populations of high affinity antibodies with mean affinity constant 5.8 x loi0 literlmol (determined by Lineweaver-Burk plot). NGF-RIA buffer contained 0.5% bovine serum albumin, 0.5% normal rabbit serum, 0.1 % sodium chloride, and 5 mM EDTA in 0.05 M phosphate buffered saline pH 7.2. The antiserum was used at a final dilution of 1:350,000. NGF-RIA is sensitive enough to detect 16-20 pgltube. Aliquots of saliva samples were diluted in RIA buffer for determination of NGF by RIA. The incubation and separation were as previously described by Grueter et al. (1 3).
EGF concentration in saliva was measured by a specific RIA using EGF antiserum containing two populations of high-affinity antibodies with mean affinity constant 1 x 10" literlmol (determined by Lineweaver-Burk plot). The EGF-RIA buffer system, incubation, and separation were as previously described by Hoath et al. (14) .
Gel exclusion column chromatography. To assess the molecular size of immunoreactive salivary NGF and EGF, Sephadex G-200 fine resin columns (0.9 x 56 cm) were equilibrated and developed at 4" C with 0.05 M phosphate buffered saline containing 1 0-4 M sodium azide. The columns were calibrated using blue dextran, Na"51 (15,000 cpm), labeled EGF (20,000 cpm), and unlabelled bovine 7-globulin and cytochrome C in separate runs. One hundred p1 of saliva were applied on each column and eluted by a descending flow (5.5 ml/h). 0.5 ml fractions were collected in siliconized glass tubes. Fractions were diluted in the RIA buffer and assayed for NGF and EGF by their respective RIA systems.
Statistics. All results were expressed as means + SEM. For multiple comparisons, the differences between means were determined by a one-way analysis of variance followed by Student's Newman Keul's test. Significance was assumed at the 5% level (p < 0.05).
RESULTS
Influence of T4 on somatic growth and serum hormones. The effects of T4 treatment on somatic growth, serum T4, T3, and SMG weights in animals sacrificed on day 3 1 are shown in Table  1 . T4 treatment caused growth retardation as indicated by the decreased body weight and body length. Both male and female mice were affected. Mean serum T4 and T3 levels were not significantly different from that of vehicle-treated animals. T4 treatment did not affect the relative SMG weights in both sexes.
Saliva proteins. The amount of protein secreted into saliva, in response to epinephrine stimulation, is shown in Figure 1A . Total amounts of protein secreted in saliva of both male and female mice on day 31 were not significantly affected by T4 treatment.
Salivary protein composition was analyzed on a polyacrylamide gel electrophoretic system in the presence of sodium dodecyl sulphate and the gel scanning results are shown in Figure  1 B. Striking differences in protein profiles for male and female mice saliva were observed. In both sexes, neonatal T4 treatment induced significant alterations. The results are described in the legend for Figure 1 B.
Changes in salivary NGF and EGF concentrations. The effects of T4 treatment on NGF concentration in saliva of male and female littermate mice are shown in Figure 2 (upper panel) . T4 treatment decreased the NGF levels in the saliva of both sexes.
The effects of T4 treatment on salivary EGF concentration are shown in Figure 2 (lower panel). T4 treatment also decreased the salivary EGF levels in both sexes. Figure 3 . In females (upper panel), NGF immunoreactivity eluted in two distinct peaks. The first peak eluted immediately after the void volume, suggesting this protein is in its high molecular weight state. The elution of this peak was completed before the y-globulin position. The second peak began to elute immediately after the 7-globulin position, suggesting this fraction of NGF is the low molecular weight state. The elution of low molecular weight NGF continued until the end of one column volume is reached, while the elution of this peak in T4-treated females was completed at a position near cytochrome C. The elution profiles of NGF-immunoreactivity in saliva of control and T4-treated male mice are shown in Figure 3 (lower panel). Although both high and low molecular weight form NGFs were observed in males, the elution of their immunoreactivities were not completed even with two column volumes of the buffer. In control males, the second immunoreactive peak appeared after cytochrome C, while this peak in T4-treated males appeared before the elution of cytochrome C.
The elution pattern of EGF immunoreactivity was similar in saliva of female and male mice (Fig. 4 , upper and lower panels). Immunoreactive EGF emerged immediately after y-globulin and peaked at a position which corresponded to standard mouse EGF of 6045 molecular weight. The elution pattern suggests that EGF is present in saliva in predominantly low molecular weight form. In both sexes, T4 treatment did not alter the elution pattern, but the amount was greatly reduced.
DISCUSSION
The present experiments were undertaken to examine the role of thyroxine on the development of secretory mechanisms specifically for NGF and EGF in mouse saliva. The dose and duration of T4 treatment used in this study were recently shown to abolish the ontogenetic peaks of serum T4 and T3 levels, which occur around day 15 in normal mice (7) . The growth responses and serum T4 and T3 levels observed in this study were similar in magnitude to those previously reported for similar age group mice (6, 7). On SDS gel electrophoresis, the saliva showed nine major bands. Protein bands 7 and 9 were found in control female mice and were absent in control male animals. Protein bands 1, 2, 4, 7, and 9 were T4 sensitive and their levels were significantly higher in the hormone-treated group. In contrast, the protein bands 5 and 8 were significantly lower in T4-treated animals. The results of SDS-PAGE analysis revealed distinct sex differences as well as different T4-induced responses In all cases, 100 fi1 of saliva was loaded on the top of the column and 0.5 ml fractions were collected. Vo, void volume (blue dextran). Vt, total volume (~a "~1 ) .
Locations of the peaks of bovine y-globulin and cytochrome C are indicated. Column elution profiles for female and male mouse saliva are shown in the upper and lower panels. in the protein constituents secreted in saliva. Neonatal hyperthyroidism did not impair common secretory mechanism since similar changes were not observed in all protein constituents secreted.
The present findings, however, reveal significant sex differences in salivary NGF and EGF concentrations. Both growth factors were secreted in higher concentrations in male compared to female mice. The existence of sex difference in adult mice saliva has previously been reported (15) . The higher levels observed in males reflect the existence of sexual dimorphism for these growth factors in the submandibular gland (16, 17) .
More recently, male and female mice that were subjected to T4 treatment with dose and duration as used in this study were found to contain low levels of NGF and EGF in SMG tissues (6, 7) . In the present study, marked decreases in salivary NGF and EGF were also observed in T4-treated male and female mice. Further studies are essential to establish whether decreases in salivary NGF and EGF levels represent the decreased glandular growth factors level or a defect in the glandular growth factor secretory mechanisms.
In this study, the epinephrine dose (3-6 mg/kg body weight), which efficiently provoked salivation in control mice was found to be less effective in T4-treated littermate animals. Hormonetreated animals often required a second dose of epinephrine injection to elicit salivation. Whether the reduced sensitivity to epinephrine represents any alteration in SMG-adrenergic receptor density is presently under investigation. In rat SMG, adrenergic receptors have been reported under the regulation of thyroid hormones (1 8). However, similar findings have not been reported in mice.
The results of Sephadex column chromatography revealed significant differences in the molecular nature of NGF and EGF secreted into saliva. Although two distinct NGF immunoreactive peaks were observed in male and female mice, the incomplete elution precluded the precise estimation of molecular weights of the secreted NGF. The elution profiles obtained for the high molecular weight form NGF showed significant differences between male and female mice. In males the high molecular weight form NGF peaked immediately after the y-globulin fraction, while in females the peak occurred prior to the y-globulin fraction. It is not clear whether the observed differences were due to different amounts of NGF or whether other proteins induced alterations in the elution profile. In both sexes, NGF immunoreactivity largely remained in the low molecular weight form. EGF immunoreactivity also largely corresponded to standard EGF of 6045 molecular weight. Interestingly, Burton et al. (19) reported absence of low molecular weight NGF and EGF in saliva of adult male mice. The data presented herein is the first report on the molecular nature of salivary NGF and EGF in mice of younger age. The results of the present study taken together with Burton et al. (19) indicate that the molecular nature of both NGF and EGF secreted into saliva may undergo more developmental changes with increasing age. Further work is necessary to determine what factor(s) regulate the conversion of low molecular weight forms into high molecular weight forms in salivary NGF and EGF secretion. Interestingly, this study indicates that T4 treatment does not alter the molecular nature of NGF and EGF secreted into saliva but the treatment greatly reduces their content.
In summary, neonatal hyperthyroidism causes impairments in the secretions of NGF and EGF into saliva, long after T4 treatment has been discontinued. The mechanism(s) of impairment remain a subject for further investigation.
